JP Morgan Rates H.B. Fuller (FUL) buy, $67 Price Target

JP Morgan analyst Jeffrey Zekauskas raises H.B. Fuller's price target to $67 with a 'buy' rating, a 13.29% upside from the current price.

By EarningsIQ Research Desk · Published Jun 26, 2026, 10:01 AM EDT · Updated Jun 30, 2026, 11:02 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

JP Morgan rated H.B. Fuller Company ($FUL) "buy" with a $67 price target on June 26, 2026.

Since the rating, $FUL is down 7.7% after 1 week, down 10.6% after 1 month and down 18.1% to date (from the $62.67 close on Jun 26, 2026).

FUL H.B. Fuller Company

$51.32 -13.50% year to date

Daily close · Oct 16, 2026

Key Points

JP Morgan analyst Jeffrey Zekauskas upgraded H.B. Fuller to a 'buy' and set a price target of $67 on June 26, 2026.
JP Morgan's $67 price target implies 13.29% upside from H.B. Fuller Company's ($FUL) current $59.14 share price.
Shares of H.B. Fuller traded at $61.95 on Friday, with a market cap of approximately $3.38 billion and a P/E ratio of 18.38.
Insider buying activity included purchases by executives like John Corkrean and Heather Campe in June 2026.

Get $FUL trade alerts by text

We text you when insiders, Congress or big funds trade $FUL. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated H.B. Fuller Company alert may contain errors. Disclosures

JP Morgan has given a boost to H.B. Fuller Company (NYSE:FUL) by upgrading its rating to 'buy' and setting a new price target of $67. The update came from analyst Jeffrey Zekauskas on June 26, 2026.

Analyst rating track record

JP Morgan vs. the S&P 500

YTD return -4.08% hypothetical

All-time return +32.74% S&P 500 +35.91%

vs. S&P 500 -3.17% behind the index

Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.

H.B. Fuller Company Stock Up 19.7%

Shares of H.B. Fuller traded at $61.95 on Friday. The company, which operates in the specialty chemicals industry, has a market cap of about $3.38 billion. Its price-to-earnings (P/E) ratio stands at 18.38, with a forward P/E of 11.82, and it has a beta of 0.962. The stock's 52-week range has been between $48.71 and $68.63. The firm maintains a current ratio of 1.915 and a quick ratio of 0.961, with a debt-to-equity ratio of 107.906.

12-month forecast

$FUL price target

H.B. Fuller Company daily closes and this analyst's $67 target. Not advice.

Recent Earnings

H.B. Fuller reported revenue of approximately $3.46 billion, though it faced a slight revenue decline of 2.3%. The company's net margin is 4.62%, and it has a return on equity of 8.32%. The next earnings report is expected on September 23, 2026.

Dividend

H.B. Fuller pays an annual dividend rate of $0.98, yielding 1.52%. The dividend payout ratio is about 32.53%.

Insider Buying and Selling at H.B. Fuller Company

Recent insider trading activity shows several executives buying shares. On June 22, 2026, Heather Campe, Sr. VP of International Growth, purchased 35 shares at $64.31 each. On the same day, John Corkrean, Executive VP and CFO, acquired 196 shares at the same price. Earlier, on June 5, 2026, Corkrean bought 211 shares at $59.88, and Campe added 37 shares at the same rate.

Analysts Set New Price Targets

On June 26, 2026, JP Morgan upgraded H.B. Fuller to a 'buy' with a $67 price target. Previously, UBS maintained a 'hold' rating with a $71 target on June 17, 2026. Citigroup has consistently rated the stock as 'buy', with targets ranging from $67 to $76 earlier in the year. The consensus among analysts is a 'buy', with a mean price target of $71.57 based on seven opinions.

About H.B. Fuller

H.B. Fuller Company, founded in 1887 and headquartered in Saint Paul, Minnesota, is a global provider of adhesives, sealants, and other specialty chemical products. It operates through segments like Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions, serving industries such as packaging, construction, and electronics. The company employs around 7,100 people under the leadership of CEO Celeste Beeks Mastin.

Bottom Line

JP Morgan's upgrade to a 'buy' rating and a new $67 target for H.B. Fuller underscores the firm's confidence in the company's prospects. Investors often look to such analyst updates for insights into a stock's potential. As always, remember that analyst ratings are forward-looking and based on current information and assumptions.